Qian-Yi Zhao et al.
COMMUNICATIONS
Compound 4 (26 mg, 0.10 mmol) was added to a solution
of N-ethyl-N’-(3-dimethylaminopropyl)carbodiimide hydro-
chloride (EDCI) (58 mg, 0.30 mmol) and 1-hydroxybenzo-
triazole (HOBt) (54 mg, 0.40 mmol) in N,N-dimethylform-
Wuitschik, M. Rogers-Evans, K. Mꢃller, E. M. Carreira,
Angew. Chem. 2010, 122, 9236–9251; Angew. Chem. Int.
Ed. 2010, 49, 9052–9067.
[2] a) Y. Shi, Acc. Chem. Res. 2004, 37, 488–496; b) O. A.
Wong, Y. Shi, Chem. Rev. 2008, 108, 3958–3987.
ACHTUNGTRENNUNGamide (DMF) (2.0 mL). The resulted mixture was stirred for
24 h at room temperature. Then, the solvent was removed
from the flask under reduced pressure. The resulting residue
was diluted with EtOAc, washed with saturated NaCl solu-
tion twice, and extracted by EtOAc. The organic layer was
dried over anhydrous Na2SO4 and concentrated under re-
duced pressure. The residue was chromatographed on silica
gel (elution with petroleum ether/EtOAc=2:1) to give com-
pound 5.
[3] K. A. Jørgensen, Eur. J. Org. Chem. 2004, 2093–2102.
[4] a) K. A. Jørgensen, Angew. Chem. 2000, 112, 3702–
3733; Angew. Chem. Int. Ed. 2000, 39, 3558–3588;
b) T. G. Kilroy, T. P. OꢀSullivan, P. J. Guiry, Eur. J. Org.
Chem. 2005, 4929–4949.
[5] a) K. Soai, S. Niwa, T. Yamanoi, H. Hikima, M. Ishiza-
ki, J. Chem. Soc. Chem. Commun. 1986, 1018–1019;
b) T. Sone, G. Lu, S. Matsunaga, M. Shibasaki, Angew.
Chem. 2009, 121, 1705–1708; Angew. Chem. Int. Ed.
2009, 48, 1677–1680; c) K. Mikami, K. Aikawa, J. Aida,
Synlett 2011, 2719–2724; d) K. Aikawa, Y. Hioki, N.
Shimizu, K. Mikami, J. Am. Chem. Soc. 2011, 133,
20092–20095.
[6] a) T. Wang, X.-Y. Chen, S. Ye, Tetrahedron Lett. 2011,
52, 5488–5490; b) L. B. Saunders, S. J. Miller, ACS
Catal. 2011, 1, 1347–1350. For an N-heterocyclic car-
bene-catalyzed [2+2+2]annulation of allenoates with
trifluoromethyl ketones, please see: c) L. Sun, T. Wang,
S. Ye, Chin. J. Chem. 2012, 30, 190–194.
Supporting Information
Experimental procedures, chiral HPLC traces, and spectro-
scopic data for all new compounds, X-ray crystal structures
and CIF data for 5 are available in the Supporting Informa-
tion.
Acknowledgements
[7] a) M. Shi, Y.-M. Xu, Angew. Chem. 2002, 114, 4689–
4692; Angew. Chem. Int. Ed. 2002, 41, 4507–4510;
b) M. Shi, Y.-M. Xu, Y.-L. Shi, Chem. Eur. J. 2005, 11,
1794–1802; c) M. Shi, Z.-Y. Lei, M.-X. Zhao, J.-W. Shi,
Tetrahedron Lett. 2007, 48, 5743–5746; d) M. Shi, X.-G.
Liu, Org. Lett. 2008, 10, 1043–1046; e) X.-Y. Guan, Y.
Wei, M. Shi, Chem. Eur. J. 2010, 16, 13617–13621; f) X.-
Y. Guan, Y. Wei, M. Shi, Eur. J. Org. Chem. 2010,
4098–4105; g) Q.-Y. Zhao, C.-K. Pei, X.-Y. Guan, M.
Shi, Adv. Synth. Catal. 2011, 353, 1973–1979; h) C.-K.
Pei, X.-C. Zhang, M. Shi, Eur. J. Org. Chem. 2011,
4479–4484; i) C.-K. Pei, M. Shi, Tetrahedron: Asymme-
try 2011, 22, 1239–1248; j) L. Huang, Y. Wei, M. Shi,
Org. Biomol. Chem. 2012, 10, 1396–1405.
[8] For reviews and other selected examples on Cinchona
alkaloids-derived organocatalysts in asymmetric cataly-
sis, see: a) A. Ting, J. M. Goss, N. T. McDougal, S. E.
Schaus, Top. Curr. Chem. 2010, 291, 145–200; b) S.-K.
Tian, Y. Chen, J. Hang, L. Tang, P. McDaid, L. Deng,
Acc. Chem. Res. 2004, 37, 621–631; c) H. C. Kolb, M. S.
VanNieuwenhze, K. B. Sharpless, Chem. Rev. 1994, 94,
2483–2547; d) S. France, D. J. Guerin, S. J. Miller, T.
Letcka, Chem. Rev. 2003, 103, 2985–3012; e) D. Basa-
vaiah, A. J. Rao, T. Satyanarayana, Chem. Rev. 2003,
103, 811–892; f) M. J. OꢀDonnell, Acc. Chem. Res. 2004,
37, 506–517; g) H. B. Jang, J. W. Lee, C. E. Song, Cin-
chona Alkaloids in Synthesis and Catalysis 2009, 197–
247; h) L.-W. Xu, J. Luo, Y. Lu, Chem. Commun. 2009,
1807–1821; i) G. Masson, C. Housseman, J. Zhu,
Angew. Chem. 2007, 119, 4698–4712; Angew. Chem.
Int. Ed. 2007, 46, 4614–4628; j) N. Abermil, G. Masson,
J. Zhu, Org. Lett. 2009, 11, 4648–4651; k) T. Marcelli,
J. H. V. Maarseveen, H. Hiemstra, Angew. Chem. 2006,
118, 7658–7666; Angew. Chem. Int. Ed. 2006, 45, 7496–
7504; l) R. P. Singh, B. M. Foxman, L. Deng, J. Am.
Chem. Soc. 2010, 132, 9558–9560; m) S. Saaby, M.
Bella, K. A. Jørgensen, J. Am. Chem. Soc. 2004, 126,
8120–8121; n) M. Bella, K. A. Jørgensen, J. Am. Chem.
We thank the Shanghai Municipal Committee of Science and
Technology (11JC1402600), National Basic Research Pro-
gram of China ACHTUNGTRENNUNG(973)-2010CB833302, the Fundamental Re-
search Funds for the Central Universities and the National
Natural Science Foundation of China for financial support
(21072206, 20872162, 20672127, 20732008, 21121062 and
20702013).
References
[1] a) S. J. Omura, Antibiotics 1984, 37, 1324–1332;
b) L. M. Dollinger, A. R. Howell, Bioorg. Med. Chem.
Lett. 1998, 8, 977–978; c) L. M. Dollinger, A. R.
Howell, J. Org. Chem. 1998, 63, 6782–6783; d) M. Ham-
berg, J. Svensson, B. Samuelsson, Proc. Natl. Acad. Sci.
USA 1975, 72, 2994–2998; e) M. C. Wani, H. L. Taylor,
M. E. Wall, P. Coggon, A. T. McPhail, J. Am. Chem.
Soc. 1971, 93, 2325–2327; f) J. R. Hanson, Nat. Prod.
Rep. 1999, 16, 209–219; g) G. Wuitschik, M. Rogers-
Evans, K. Mꢃller, H. Fischer, B. Wagner, F. Schuler, L.
Polonchuk, E. M. Carreira, Angew. Chem. 2006, 118,
7900–7903; Angew. Chem. Int. Ed. 2006, 45, 7736–7739;
h) G. Wuitschik, M. Rogers-Evans, A. Buckl, M. Ber-
nasconi, M. Mꢄrki, T. Godel, H. Fischer, B. Wagner, I.
Parrilla, F. Schuler, J. Schneider, A. Alker, W. B.
Schweizer, K. Mꢃller, E. M. Carreira, Angew. Chem.
2008, 120, 4588–4591; Angew. Chem. Int. Ed. 2008, 47,
4512–4515; i) G. Wuitschik, E. M. Carreira, M. Rogers-
Evans, K. Mꢃller, in: Process Chemistry in the Pharma-
ceutical Industry, (Eds.: K. Gadamasetti, T. Braish),
CRC, Boca Raton, 2008, pp 217–229; j) details can be
found in: G. Wuitschik, PhD Thesis, ETH Zurich (Swit-
zerland), 2008, DOI: 10.3929/ethz-a-005697432; k) G.
Wuischik, E. M. Carreira, B. Wagner, H. Fischer, I. Par-
rilla, F. Schuler, M. Rogers-Evans, K. Mꢃller, J. Med.
Chem. 2010, 53, 3227–3246; l) N. A. Meanwell, J. Med.
Chem. 2011, 54, 2529–2591; m) J. A. Burkhard, G.
6
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 0000, 000, 0 – 0
ÝÝ
These are not the final page numbers!